BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 35432329)

  • 1. PAD4 Immunization Triggers Anti-Citrullinated Peptide Antibodies in Normal Mice: Analysis With Peptide Arrays.
    Hemon MF; Lambert NC; Arnoux F; Roudier J; Auger I
    Front Immunol; 2022; 13():840035. PubMed ID: 35432329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptidyl arginine deiminase immunization induces anticitrullinated protein antibodies in mice with particular MHC types.
    Arnoux F; Mariot C; Peen E; Lambert NC; Balandraud N; Roudier J; Auger I
    Proc Natl Acad Sci U S A; 2017 Nov; 114(47):E10169-E10177. PubMed ID: 29109281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptidylarginine Deiminase Autoimmunity and the Development of Anti-Citrullinated Protein Antibody in Rheumatoid Arthritis: The Hapten-Carrier Model.
    Auger I; Balandraud N; Massy E; Hemon MF; Peen E; Arnoux F; Mariot C; Martin M; Lafforgue P; Busnel JM; Roudier J
    Arthritis Rheumatol; 2020 Jun; 72(6):903-911. PubMed ID: 31820586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do RA associated HLA-DR molecules bind citrullinated peptides or peptides from PAD4 to help the development of RA specific antibodies to citrullinated proteins?
    Balandraud N; Auger I; Roudier J
    J Autoimmun; 2021 Jan; 116():102542. PubMed ID: 32928608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of autoantibodies to citrullinated BiP in rheumatoid arthritis patients and pro-inflammatory role of citrullinated BiP in collagen-induced arthritis.
    Shoda H; Fujio K; Shibuya M; Okamura T; Sumitomo S; Okamoto A; Sawada T; Yamamoto K
    Arthritis Res Ther; 2011; 13(6):R191. PubMed ID: 22108001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of potential autoantigens in anti-CCP-positive and anti-CCP-negative rheumatoid arthritis using citrulline-specific protein arrays.
    Poulsen TBG; Damgaard D; Jørgensen MM; Senolt L; Blackburn JM; Nielsen CH; Stensballe A
    Sci Rep; 2021 Aug; 11(1):17300. PubMed ID: 34453079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophage extracellular traps require peptidylarginine deiminase 2 and 4 and are a source of citrullinated antigens bound by rheumatoid arthritis autoantibodies.
    Bashar SJ; Holmes CL; Shelef MA
    Front Immunol; 2024; 15():1167362. PubMed ID: 38476240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fine specificity of anti-citrullinated peptide antibodies discloses a heterogeneous antibody population in rheumatoid arthritis.
    Goules JD; Goules AV; Tzioufas AG
    Clin Exp Immunol; 2013 Oct; 174(1):10-7. PubMed ID: 23711220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative analysis of autoantibodies targeting peptidylarginine deiminase type 4, mutated citrullinated vimentin and cyclic citrullinated peptides in rheumatoid arthritis: associations with cytokine profiles, clinical and genetic features.
    Reyes-Castillo Z; Palafox-Sánchez CA; Parra-Rojas I; Martínez-Bonilla GE; del Toro-Arreola S; Ramírez-Dueñas MG; Ocampo-Bermudes G; Muñoz-Valle JF
    Clin Exp Immunol; 2015 Nov; 182(2):119-31. PubMed ID: 26149185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relative efficiencies of peptidylarginine deiminase 2 and 4 in generating target sites for anti-citrullinated protein antibodies in fibrinogen, alpha-enolase and histone H3.
    Damgaard D; Bawadekar M; Senolt L; Stensballe A; Shelef MA; Nielsen CH
    PLoS One; 2018; 13(8):e0203214. PubMed ID: 30161253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-citrullinated protein antibodies as biomarkers in rheumatoid arthritis.
    Trier NH; Houen G
    Expert Rev Mol Diagn; 2023; 23(10):895-911. PubMed ID: 37578277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presence and role of anti-citrullinated protein antibodies in experimental arthritis models.
    Cantaert T; Teitsma C; Tak PP; Baeten D
    Arthritis Rheum; 2013 Apr; 65(4):939-48. PubMed ID: 23280233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-PAD4 autoantibodies in rheumatoid arthritis: levels in serum over time and impact on PAD4 activity as measured with a small synthetic substrate.
    Pollmann S; Stensland M; Halvorsen EH; Sollid LM; Kvien TK; Fleckenstein B; Molberg O
    Rheumatol Int; 2012 May; 32(5):1271-6. PubMed ID: 21267570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-Titer Rheumatoid Arthritis Antibodies Preferentially Bind Fibrinogen Citrullinated by Peptidylarginine Deiminase 4.
    Blachère NE; Parveen S; Frank MO; Dill BD; Molina H; Orange DE
    Arthritis Rheumatol; 2017 May; 69(5):986-995. PubMed ID: 28029744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Citrulline Not a Major Determinant in the Recognition of Peptidylarginine Deiminase 2 and 4 by Autoantibodies in Rheumatoid Arthritis.
    Darrah E; Davis RL; Curran AM; Naik P; Chen R; Na CH; Giles JT; Andrade F
    Arthritis Rheumatol; 2020 Sep; 72(9):1476-1482. PubMed ID: 32255561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PAD2 immunization induces ACPA in wild-type and HLA-DR4 humanized mice.
    Hemon MF; Lambert NC; Roudier J; Auger I
    Eur J Immunol; 2022 Sep; 52(9):1464-1473. PubMed ID: 35712879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The fine specificity of IgM anti-citrullinated protein antibodies (ACPA) is different from that of IgG ACPA.
    Suwannalai P; Willemze A; van Toorn L; Stoeken-Rijsbergen G; Levarht N; Drijfhout JW; Huizinga TW; Toes RE; Trouw LA
    Arthritis Res Ther; 2011; 13(6):R195. PubMed ID: 22129077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of an immunodominant peptide from citrullinated tenascin-C as a major target for autoantibodies in rheumatoid arthritis.
    Schwenzer A; Jiang X; Mikuls TR; Payne JB; Sayles HR; Quirke AM; Kessler BM; Fischer R; Venables PJ; Lundberg K; Midwood KS
    Ann Rheum Dis; 2016 Oct; 75(10):1876-83. PubMed ID: 26659718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptidylarginine deiminase 4 contributes to tumor necrosis factor α-induced inflammatory arthritis.
    Shelef MA; Sokolove J; Lahey LJ; Wagner CA; Sackmann EK; Warner TF; Wang Y; Beebe DJ; Robinson WH; Huttenlocher A
    Arthritis Rheumatol; 2014 Jun; 66(6):1482-91. PubMed ID: 24497204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microchimeric cells promote production of rheumatoid arthritis-specific autoantibodies.
    Hemon M; Giassi M; Ghaffar Y; Martin M; Roudier J; Auger I; Lambert NC
    J Autoimmun; 2024 Jun; 146():103238. PubMed ID: 38754239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.